Fresenius Kabi Opens Injectables Mfg Facility in IndonesiaBy
Fresenius Kabi, a Lake Zurich, Illinois-headquartered specialty and generic pharmaceuticals company and a subsidiary of Fresenius KGaA, a Bad Homburg, Germany-headquartered healthcare group, is expanding its activities in Indonesia. PT Ethica Industri Farmasi, a joint venture of Fresenius Kabi and the Indonesian pharmaceutical company, SOHO Global Health, have opened a new plant in Cikarang, Indonesia. The plant’s approximately 230 employees plan to produce a range of injectable drugs for therapeutic areas, including gynecology, anesthesia, and intensive care. The products are planned for use by Indonesian patients and for export to other Southeast Asian countries, according to Fresenius Kabi. Fresenius Kabi employs a total of approximately 530 people in Indonesia.
Earlier this week, Fresenius Kabi also announced it plans to invest $100 million to expand its sterile injectable manufacturing operations in Wilson County, North Carolina. This includes the expansion of its current pharmaceutical production facility in Wilson and the construction of a new manufacturing facility, also in Wilson.
Source: Fresenius Kabi